Showing results (1-10 of 756) with videos related to
Sort By:
Pageof 76
The Lancet. Gastroenterology & Hepatology|April 21, 2019
Optimal dilation time for combined small endoscopic sphincterotomy and balloon dilation for common bile duct stones: a multicentre, single-blinded, randomised controlled trialWenbo Meng, Joseph W Leung, Kai Zhang, et al.The Lancet. Gastroenterology & Hepatology|July 18, 2020
Standard gastroenterologist versus multidisciplinary treatment for functional gastrointestinal disorders (MANTRA): an open-label, single-centre, randomised controlled trialChamara Basnayake, Michael A Kamm, Annalise Stanley, et al.The Lancet. Gastroenterology & Hepatology|May 7, 2023
Impact and cost-effectiveness of hepatitis B virus prophylaxis in pregnancy: a dynamic simulation modelling studyShevanthi Nayagam, Margaret J de Villiers, Yusuke Shimakawa, et al.The Lancet. Gastroenterology & Hepatology|May 21, 2023
Overlap of disorders of gut-brain interaction: a systematic review and meta-analysisThomas Fairlie, Ayesha Shah, Nicholas J Talley, et al.The Lancet. Gastroenterology & Hepatology|February 5, 2018
Napabucasin versus placebo in refractory advanced colorectal cancer: a randomised phase 3 trialDerek J Jonker, Louise Nott, Takayuki Yoshino, et al.The Lancet. Gastroenterology & Hepatology|March 18, 2018
Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-seriesKeri E Lunsford, Milind Javle, Kirk Heyne, et al.The Lancet. Gastroenterology & Hepatology|January 10, 2018
Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trialJason Grebely, Olav Dalgard, Brian Conway, et al.The Lancet. Gastroenterology & Hepatology|March 31, 2018
Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling studyThe Lancet. Gastroenterology & Hepatology|February 11, 2018
Perioperative lipid-enriched enteral nutrition versus standard care in patients undergoing elective colorectal surgery (SANICS II): a multicentre, double-blind, randomised controlled trialEmmeline G Peters, Boudewijn J J Smeets, Jesper Nors, et al.The Lancet. Gastroenterology & Hepatology|November 5, 2017
Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trialPeter Holger Johnsen, Frank Hilpüsch, Jorunn Pauline Cavanagh, et al.Pageof 76